echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The new fusion protein still has killing effect on infection caused by Gram-positive bacteria

    The new fusion protein still has killing effect on infection caused by Gram-positive bacteria

    • Last Update: 2017-12-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, published in the latest issue of Journal of immunology, researchers from Lund University in Sweden and researchers from the University of Massachusetts Medical School found that the protein killing Gram-negative bacteria had the same bactericidal effect on Gram-positive bacteria Complement system is an important part of our body's natural immune system, which can protect us from the infection of pathogenic microorganisms, but because it is too strong, it needs to be carefully controlled to avoid damage to the body's own cells Factor H is a kind of regulatory element that controls complement reaction The protein can circulate in the blood system and protect the body from the attack of complement molecules: when the cell surface is covered with factor H, it can successfully avoid the recognition of complement system Previous studies have shown that a special fusion protein designed by Professor Sanjay ram from Massachusetts Medical College can effectively resist the infection of mice caused by gram-negative bacteria (gonorrhea, meningitis, respiratory tract infection, etc.), while pathogenic bacteria can use factor H to escape the immune killing of the organism Now, researchers have found that these fusion proteins can still kill infection caused by Gram-positive bacteria In fact, the protein can block the activity of factor H molecule covered on the surface of bacteria, thus activating the immune response The researchers hope to study whether the protein can have the same therapeutic effect on infections caused by multiple drug-resistant bacteria.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.